AJG: Analysis of the prevalence of gastrointestinal symptoms in patients infected with COVID-19

Patients with new coronary pneumonia ( COVID-19 ) who have gastrointestinal symptoms will have a higher chance of developing severe illness
.

Although the name of the disease caused by the new coronavirus is pneumonia, the receptor of the virus is expressed in almost all tissues of the body, especially in the gastrointestinal tract

Patients with new coronary pneumonia ( COVID-19 ) who have gastrointestinal symptoms will have a higher chance of developing severe illness

 

GI-COVID-19 is a prospective, multi-center, controlled study
.

Researchers recruited patients with confirmed and undiagnosed COVID-19 at the time of admission, and used a validated gastrointestinal symptom rating scale questionnaire to ask about gastrointestinal symptoms at admission and one month later, and finally conducted a correlation analysis

 

The results of the study showed that the study included 2,036 hospitalized patients, including a total of 871 patients (575 COVID-19+ (positive) and 296 COVID-19- (negative))
.

Compared with the control group (43.

 

This study confirmed that the prevalence of gastrointestinal symptoms in COVID-19 hospitalized patients was higher than that of the control group
.

Systemic and respiratory symptoms are usually related to gastrointestinal discomfort, but nausea may persist after the COVID-19 infection subsides

This study confirmed that the prevalence of gastrointestinal symptoms in COVID-19 hospitalized patients was higher than that of the control group

Marasco, Giovanni MD.

Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study.
Leave a message here